Elevance Health Inc (ELV) Common Stock USD0.01
Sell:$348.74Buy:$348.79
$0.59
(0.17%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$348.74
Buy:$348.79
Change:$0.59
(0.17%)
$0.59
(0.17%)Prices delayed by at least 15 minutes
Sell:$348.74
Buy:$348.79
Change:$0.59
(0.17%)
$0.59
(0.17%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 October 2025 | Mark Bradley KayeCFO | Sell Tax related | 2,895 | $340.24 | $984,994.80 | 16,082 |
| 3 September 2025 | Erin M WesslingChief Legal/Compliance Officer | Sell Tax related | 152 | $321.59 | $48,881.68 | 5,020 |
| 19 August 2025 | Susan D DevoreDirector | Buy Regular purchase transaction | 1,200 | $312.15 | $374,580.00 | 3,502 |
| 18 July 2025 | Gail Koziara BoudreauxPresident/CEO | Buy Regular purchase transaction | 1,050 | $287.96 | $302,358.00 | 151,020 |
| 18 July 2025 | Gail Koziara BoudreauxPresident/CEO | Buy Regular purchase transaction | 5,116 | $287.12 | $1,468,905.92 | 149,970 |
| 18 July 2025 | Gail Koziara BoudreauxPresident/CEO | Buy Regular purchase transaction | 2,334 | $286.07 | $667,687.38 | 144,854 |
| 24 April 2025 | Mark Bradley KayeCFO | Sell Regular sell transaction (market) | 4,588 | $424.82 | $1,949,074.16 | 18,977 |
| 10 March 2025 | Ronald William PenczekChief Accounting Officer | Sell Regular sell transaction (market) | 443 | $415.13 | $183,902.59 | 1,847 |
| 5 March 2025 | Charles Morgan Jr. KendrickOther President | Sell Option/Award related | 3,504 | $396.30 | $1,388,635.20 | 10,116 |
| 3 March 2025 | Gail Koziara BoudreauxPresident/CEO | Sell Tax related | 10,396 | $395.50 | $4,111,618.00 | 116,313 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 March 2025 | Gail Koziara BoudreauxPresident/CEO | Sell Tax related | 10,396 | $395.50 | $4,111,618.00 | 116,313 |
| 24 April 2025 | Mark Bradley KayeCFO | Sell Regular sell transaction (market) | 4,588 | $424.82 | $1,949,074.16 | 18,977 |
| 18 July 2025 | Gail Koziara BoudreauxPresident/CEO | Buy Regular purchase transaction | 5,116 | $287.12 | $1,468,905.92 | 149,970 |
| 5 March 2025 | Charles Morgan Jr. KendrickOther President | Sell Option/Award related | 3,504 | $396.30 | $1,388,635.20 | 10,116 |
| 3 March 2025 | Felicia F NorwoodOther President | Sell Tax related | 2,613 | $395.50 | $1,033,441.50 | 24,691 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.